Cargando…

SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers

OBJECTIVE: To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. METHODS: We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 – October 15, 2020. The survey covered demographics, COVID-19 symptoms, and ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Clipman, Steven J., Wesolowski, Amy, Mehta, Shruti H., Agarwal, Smisha, Cobey, Sarah E., Cummings, Derek A.T., Gibson, Dustin G., Labrique, Alain B., Kirk, Gregory D., Solomon, Sunil S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781341/
https://www.ncbi.nlm.nih.gov/pubmed/33398298
http://dx.doi.org/10.1101/2020.12.23.20248789
_version_ 1783631657624928256
author Clipman, Steven J.
Wesolowski, Amy
Mehta, Shruti H.
Agarwal, Smisha
Cobey, Sarah E.
Cummings, Derek A.T.
Gibson, Dustin G.
Labrique, Alain B.
Kirk, Gregory D.
Solomon, Sunil S.
author_facet Clipman, Steven J.
Wesolowski, Amy
Mehta, Shruti H.
Agarwal, Smisha
Cobey, Sarah E.
Cummings, Derek A.T.
Gibson, Dustin G.
Labrique, Alain B.
Kirk, Gregory D.
Solomon, Sunil S.
author_sort Clipman, Steven J.
collection PubMed
description OBJECTIVE: To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. METHODS: We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 – October 15, 2020. The survey covered demographics, COVID-19 symptoms, and experiences around SARS-CoV-2 PCR testing in the prior 2 weeks. Logistic regression was used to analyze associations with outcomes of interest. RESULTS: Overall, 316 (10%) of 3,058 respondents wanted/needed a test in the two weeks prior to the survey. Of these, 166 (53%) were able to get tested and 156 (94%) received results; 53% waited ≥ 8 days to get results from when they wanted/needed a test. There were no significant differences by state. Among those wanting/needing a test, getting tested was significantly less common among men (aOR: 0.46) and those reporting black race (aOR: 0.53) and more common in those reporting recent travel (aOR: 3.35). CONCLUSIONS: There is an urgent need for a national communication strategy on who should get tested and where one can get tested. Additionally, measures need to be taken to improve access and reduce turn-around-time.
format Online
Article
Text
id pubmed-7781341
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-77813412021-01-05 SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers Clipman, Steven J. Wesolowski, Amy Mehta, Shruti H. Agarwal, Smisha Cobey, Sarah E. Cummings, Derek A.T. Gibson, Dustin G. Labrique, Alain B. Kirk, Gregory D. Solomon, Sunil S. medRxiv Article OBJECTIVE: To characterize the SARS-CoV-2 testing cascade and associated barriers in three US states. METHODS: We recruited participants from Florida, Illinois, and Maryland (~1000/state) for an online survey September 16 – October 15, 2020. The survey covered demographics, COVID-19 symptoms, and experiences around SARS-CoV-2 PCR testing in the prior 2 weeks. Logistic regression was used to analyze associations with outcomes of interest. RESULTS: Overall, 316 (10%) of 3,058 respondents wanted/needed a test in the two weeks prior to the survey. Of these, 166 (53%) were able to get tested and 156 (94%) received results; 53% waited ≥ 8 days to get results from when they wanted/needed a test. There were no significant differences by state. Among those wanting/needing a test, getting tested was significantly less common among men (aOR: 0.46) and those reporting black race (aOR: 0.53) and more common in those reporting recent travel (aOR: 3.35). CONCLUSIONS: There is an urgent need for a national communication strategy on who should get tested and where one can get tested. Additionally, measures need to be taken to improve access and reduce turn-around-time. Cold Spring Harbor Laboratory 2020-12-24 /pmc/articles/PMC7781341/ /pubmed/33398298 http://dx.doi.org/10.1101/2020.12.23.20248789 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Clipman, Steven J.
Wesolowski, Amy
Mehta, Shruti H.
Agarwal, Smisha
Cobey, Sarah E.
Cummings, Derek A.T.
Gibson, Dustin G.
Labrique, Alain B.
Kirk, Gregory D.
Solomon, Sunil S.
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
title SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
title_full SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
title_fullStr SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
title_full_unstemmed SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
title_short SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
title_sort sars-cov-2 testing in florida, illinois, and maryland: access and barriers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781341/
https://www.ncbi.nlm.nih.gov/pubmed/33398298
http://dx.doi.org/10.1101/2020.12.23.20248789
work_keys_str_mv AT clipmanstevenj sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT wesolowskiamy sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT mehtashrutih sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT agarwalsmisha sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT cobeysarahe sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT cummingsderekat sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT gibsondusting sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT labriquealainb sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT kirkgregoryd sarscov2testinginfloridaillinoisandmarylandaccessandbarriers
AT solomonsunils sarscov2testinginfloridaillinoisandmarylandaccessandbarriers